The RADAR-AD study aims at leveraging different combinations of wearables and smartphone applications in three different settings: during a lab assessment visit, at home and in a fully equipped digital smart home. To achieve this goal, the RADAR-AD consortium has selected wearable devices and built applications that can collect digital biomarkers for critical functional domains in people living with Alzheimer’s disease (AD). The preliminary results from the use of some of these devices and apps (gait measured via the Physilog, cognition via the Altoida app, the ability to measure finances via a Banking app) were presented at this year’s Alzheimer's Association International Conference (AAIC), which was a hybrid event, taking place in Denver, Colorado, USA and online, between 26 and 30 July 2021. The preliminary results are promising and the RADAR-AD consortium will continue investigating whether remote monitoring technologies are able to provide sensitive measures to detect functional decline in the early stages of AD.
Read more here.
